SA’s healthcare funding model could squeeze household affordability, destabilise parts of the private sector and push more patients into a public system already under strain, wrote Luyanda Njilo, senior research analyst at Nedbank Corporate & Investment Banking in Business Day (6 Feb 2026).
Sales of GLP-1 weight-loss medicines are rising rapidly in SA, mirroring global trends, but concerns about serious side effects are also growing. – Medical Brief (5 Feb 2026)
President Cyril Ramaphosa and Health Minister Dr Aaron Motsoaledi requested the Constitutional Court to overturn the Gauteng High Court judgment in May 2025 declaring that the NHI Act is reviewable. – MedicalBrief (4Feb 2026)
SA’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover less than 25% of the target population, reported Financial Mail (5 Feb 2026).